Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Siegel

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Current Psychiatry Reports|May 18, 2011
What can we expect from long-acting formulations for schizophrenia?Steven J Siegel
Current Psychiatry Reports|July 25, 2013
Capacity, confidentiality and consequences: balancing responsible medical care with mental health lawSteven J Siegel
Expert Review of Neurotherapeutics|October 9, 2009
Increased patient autonomy through long-term antipsychotic delivery systems for the treatment of schizophreniaSteven J Siegel
Psychiatry (Edgmont (Pa. : Township))|December 15, 2010
Extended release drug delivery strategies in psychiatry: theory to practiceSteven J Siegel
Current Psychiatry Reports|April 29, 2010
Resurgence of long-acting antipsychotic formulationsSteven J Siegel
Biological Psychiatry|September 8, 2016
Metabotropic Glutamate Receptor 5 as a Point of Convergence for Models of Obsessive-Compulsive Disorder and Autism Spectrum DisorderNatalie Matosin, Steven J Siegel
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 11, 2014
[Ketamine alters socially-evoked activity in the amygdala]Takuma Mihara, Steven J Siegel
Polymers|May 12, 2012
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierHirenkumar K Makadia, Steven J Siegel
Annual Review of Microbiology|October 22, 2015
Mechanisms of Bacterial Colonization of the Respiratory TractSteven J Siegel, Jeffrey N Weiser
International Review of Neurobiology|October 17, 2015
The Role of Nicotine in SchizophreniaRobert E Featherstone, Steven J Siegel
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Current Psychiatry Reports|May 18, 2011
What can we expect from long-acting formulations for schizophrenia?Steven J Siegel
Current Psychiatry Reports|July 25, 2013
Capacity, confidentiality and consequences: balancing responsible medical care with mental health lawSteven J Siegel
Expert Review of Neurotherapeutics|October 9, 2009
Increased patient autonomy through long-term antipsychotic delivery systems for the treatment of schizophreniaSteven J Siegel
Psychiatry (Edgmont (Pa. : Township))|December 15, 2010
Extended release drug delivery strategies in psychiatry: theory to practiceSteven J Siegel
Current Psychiatry Reports|April 29, 2010
Resurgence of long-acting antipsychotic formulationsSteven J Siegel
Biological Psychiatry|September 8, 2016
Metabotropic Glutamate Receptor 5 as a Point of Convergence for Models of Obsessive-Compulsive Disorder and Autism Spectrum DisorderNatalie Matosin, Steven J Siegel
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 11, 2014
[Ketamine alters socially-evoked activity in the amygdala]Takuma Mihara, Steven J Siegel
Polymers|May 12, 2012
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierHirenkumar K Makadia, Steven J Siegel
Annual Review of Microbiology|October 22, 2015
Mechanisms of Bacterial Colonization of the Respiratory TractSteven J Siegel, Jeffrey N Weiser
International Review of Neurobiology|October 17, 2015
The Role of Nicotine in SchizophreniaRobert E Featherstone, Steven J Siegel
Pageof 14